每經AI快訊，華(hua)海藥(yao)(yao)(yao)業（SH 600521，收盤價(jia)：19.92元）3月29日晚(wan)間發布公(gong)(gong)告稱，2023年3月29日，浙(zhe)江華(hua)海藥(yao)(yao)(yao)業股(gu)份有限(xian)公(gong)(gong)司參加(jia)了國家組(zu)織藥(yao)(yao)(yao)品(pin)(pin)(pin)集(ji)中(zhong)(zhong)(zhong)(zhong)(zhong)采(cai)(cai)購(gou)和(he)使用聯(lian)合(he)采(cai)(cai)購(gou)辦公(gong)(gong)室組(zu)織的(de)第八批全國藥(yao)(yao)(yao)品(pin)(pin)(pin)集(ji)中(zhong)(zhong)(zhong)(zhong)(zhong)采(cai)(cai)購(gou)的(de)投標(biao)(biao)工作，公(gong)(gong)司產(chan)品(pin)(pin)(pin)氯(lv)沙坦(tan)鉀(jia)氫(qing)氯(lv)噻嗪(qin)片(pian)、非(fei)洛(luo)地(di)(di)平緩釋片(pian)和(he)注(zhu)射用伏立康唑(zuo)擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)選(xuan)(xuan)(xuan)本次集(ji)中(zhong)(zhong)(zhong)(zhong)(zhong)采(cai)(cai)購(gou)。本次藥(yao)(yao)(yao)品(pin)(pin)(pin)集(ji)中(zhong)(zhong)(zhong)(zhong)(zhong)采(cai)(cai)購(gou)中(zhong)(zhong)(zhong)(zhong)(zhong)，擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)選(xuan)(xuan)(xuan)藥(yao)(yao)(yao)品(pin)(pin)(pin)名稱、價(jia)格(ge)、數(shu)量(liang)(liang)(liang)分別(bie)為(wei)：擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)標(biao)(biao)藥(yao)(yao)(yao)品(pin)(pin)(pin)氯(lv)沙坦(tan)鉀(jia)氫(qing)氯(lv)噻嗪(qin)片(pian)，擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)選(xuan)(xuan)(xuan)價(jia)格(ge)0.149，擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)選(xuan)(xuan)(xuan)數(shu)量(liang)(liang)(liang)17338.4。擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)標(biao)(biao)藥(yao)(yao)(yao)品(pin)(pin)(pin)非(fei)洛(luo)地(di)(di)平緩釋片(pian)，擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)選(xuan)(xuan)(xuan)價(jia)格(ge)0.165，擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)選(xuan)(xuan)(xuan)數(shu)量(liang)(liang)(liang)17133.28。擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)標(biao)(biao)藥(yao)(yao)(yao)品(pin)(pin)(pin)非(fei)洛(luo)地(di)(di)平緩釋片(pian)，擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)選(xuan)(xuan)(xuan)價(jia)格(ge)0.097，擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)選(xuan)(xuan)(xuan)數(shu)量(liang)(liang)(liang)1016.56。擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)標(biao)(biao)藥(yao)(yao)(yao)品(pin)(pin)(pin)注(zhu)射用伏立康唑(zuo)，擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)選(xuan)(xuan)(xuan)價(jia)格(ge)47.5，擬(ni)(ni)(ni)(ni)中(zhong)(zhong)(zhong)(zhong)(zhong)選(xuan)(xuan)(xuan)數(shu)量(liang)(liang)(liang)10.9。2022年前三季度(du)，公(gong)(gong)司該產(chan)品(pin)(pin)(pin)在國內市場并未產(chan)生銷售。

2021年(nian)1至12月(yue)份，華海藥業(ye)(ye)的營業(ye)(ye)收入(ru)構成為：成品藥銷售(shou)(shou)占比(bi)54.88%，原材料(liao)及中間體銷售(shou)(shou)占比(bi)41.71%，進出口貿易占比(bi)2.09%，技術服(fu)務占比(bi)0.69%，其他行業(ye)(ye)占比(bi)0.01%。

華海藥業的董(dong)事(shi)長是李宏，男，62歲，學(xue)歷背景為本科(ke)；總經理是陳保華，男，61歲，學(xue)歷背景為本科(ke)。

截至發稿，華海(hai)藥(yao)業市值為(wei)296億元。

道(dao)達號（daoda1997）“個股趨勢”提醒：
1. 華海藥業近30日內北向資金持股量增加69.03萬股，占流通股比例增加0.05%；
2. 近30日內無機構對華海藥業進行調研。
更多個股(gu)趨勢信息，請搜索微信公(gong)眾號“道達(da)號”，回復“查(cha)詢(xun)”，領取免費查(cha)詢(xun)權限！

每經頭條（nbdtoutiao）——

(記者 蔡鼎)

免(mian)責聲明：本文(wen)內容與數據僅(jin)供參考，不(bu)構成投資建議，使(shi)用(yong)前請核(he)實。據此操作(zuo)，風險自(zi)擔。